Related Experiment Video
Updated: Aug 31, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Tumor Microenvironment-Responsive Cu/CaCO3 -Based Nanoregulator for Mitochondrial Homeostasis Disruption-Enhanced
Yajie Zhao1,2, Yulong Bian1,2, Xiao Xiao1,2
1State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, 130022, P. R. China.
Abstract:
The efficiency of reactive oxygen species (ROS)-mediated cancer therapy is restrained by intrinsic characteristics in the tumor microenvironment (TME), such as overexpressed glutathione (GSH), hypoxia and limited efficiency of H2 O2 . In this work, intelligent copper-dropped calcium carbonate loading sonosensitizer Ce6 nanoparticles (Cu/CaCO3 @Ce6, CCC NPs) are established to realize TME-responsive self-supply of oxygen and successively Ca2+ -overloading-strengthened chemodynamic therapy/sonodynamic therapy (CDT/SDT). CCC NPs release Ca2+ , Cu2+ , and Ce6 in weakly acid and GSH-excessive TME. Released Cu2+ can not only consume GSH and turn into Cu+ via a redox reaction, but also provide CDT-creating hydroxyl radicals through the Fenton-like reaction. Under ultrasound irradiation, the intracellular oxidative stress is amplified profoundly relying on singlet oxygen outburst from SDT. Moreover, Ca2+ influx aggravates the mitochondrial disruption, which further accelerates the oxidation level. The facile and feasible design of the Cu-dropped CaCO3 -based nanoregulators will be further developed as a paradigm in ROS-contributed cancer therapy.
Insights
Intelligent nanoparticles deliver oxygen and ions to tumor sites, enhancing cancer therapy by generating reactive oxygen species (ROS) through chemodynamic and sonodynamic approaches.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cancer Therapy
Background:
- Tumor microenvironment (TME) characteristics like high glutathione (GSH) and hypoxia limit reactive oxygen species (ROS) cancer therapy.
- Existing therapies struggle with insufficient hydrogen peroxide (H2O2) levels in the TME.
Purpose of the Study:
- To develop TME-responsive nanoparticles for enhanced ROS-mediated cancer therapy.
- To overcome limitations of GSH, hypoxia, and low H2O2 in the TME.
Main Methods:
- Fabrication of intelligent copper-dropped calcium carbonate loading sonosensitizer Ce6 nanoparticles (Cu/CaCO3@Ce6, CCC NPs).
- Utilizing CCC NPs for TME-responsive self-supply of oxygen.
- Employing Ca2+ and Cu2+ release for enhanced chemodynamic therapy (CDT) and sonodynamic therapy (SDT).
Main Results:
- CCC NPs release Ca2+, Cu2+, and Ce6 in the TME, consuming GSH and generating hydroxyl radicals via Fenton-like reactions.
- Ultrasound irradiation amplifies oxidative stress through singlet oxygen release (SDT).
- Ca2+ influx disrupts mitochondria, further increasing oxidative stress.
Conclusions:
- The developed CCC NPs effectively address TME limitations for ROS-cancer therapy.
- Ca2+-overloading-strengthened CDT/SDT offers a promising strategy for cancer treatment.
- Cu-dropped CaCO3-based nanoregulators represent a new paradigm in ROS-contributed cancer therapy.
More Related Videos
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
09:24Generation of Microtumors Using 3D Human Biogel Culture System and Patient-derived Glioblastoma Cells for Kinomic Profiling and Drug Response Testing
Published on: June 9, 2016
Related Concept Videos
The Tumor Microenvironment
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...